位置:首页 > 蛋白库 > SHRM2_XENTR
SHRM2_XENTR
ID   SHRM2_XENTR             Reviewed;        1726 AA.
AC   Q09JY9;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 1.
DT   03-AUG-2022, entry version 65.
DE   RecName: Full=Protein Shroom2;
DE   AltName: Full=Protein Apxl;
GN   Name=shroom2; Synonyms=apxl;
OS   Xenopus tropicalis (Western clawed frog) (Silurana tropicalis).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Silurana.
OX   NCBI_TaxID=8364;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=16987870; DOI=10.1242/dev.02563;
RA   Fairbank P.D., Lee C., Ellis A., Hildebrand J.D., Gross J.M.,
RA   Wallingford J.B.;
RT   "Shroom2 (APXL) regulates melanosome biogenesis and localization in the
RT   retinal pigment epithelium.";
RL   Development 133:4109-4118(2006).
CC   -!- FUNCTION: May be involved in endothelial cell morphology changes during
CC       cell spreading. Required for eye pigmentation. In the retinal pigment
CC       epithelium, regulates the biogenesis of melanosomes and promotes their
CC       association with the apical cell surface by inducing gamma-tubulin
CC       redistribution. {ECO:0000269|PubMed:16987870}.
CC   -!- SUBUNIT: Interacts with F-actin. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000250}. Cell
CC       junction, tight junction {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000250}. Note=Associates with cortical F-actin. {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: At stage 25, expressed throughout the eye field.
CC       At stage 40, expression becomes restricted to the retinal pigment
CC       epithelium. {ECO:0000269|PubMed:16987870}.
CC   -!- DOMAIN: The ASD1 domain mediates F-actin binding. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the shroom family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ886532; ABI63573.1; -; mRNA.
DR   RefSeq; NP_001072178.1; NM_001078710.1.
DR   AlphaFoldDB; Q09JY9; -.
DR   SMR; Q09JY9; -.
DR   STRING; 8364.ENSXETP00000060716; -.
DR   PaxDb; Q09JY9; -.
DR   GeneID; 779568; -.
DR   KEGG; xtr:779568; -.
DR   CTD; 357; -.
DR   Xenbase; XB-GENE-982291; shroom2.
DR   eggNOG; ENOG502QUU2; Eukaryota.
DR   InParanoid; Q09JY9; -.
DR   OrthoDB; 29607at2759; -.
DR   Proteomes; UP000008143; Chromosome 2.
DR   Proteomes; UP000790000; Unplaced.
DR   GO; GO:0005912; C:adherens junction; IBA:GO_Central.
DR   GO; GO:0043296; C:apical junction complex; IBA:GO_Central.
DR   GO; GO:0016324; C:apical plasma membrane; IMP:HGNC-UCL.
DR   GO; GO:0005923; C:bicellular tight junction; ISS:UniProtKB.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; ISS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0003779; F:actin binding; ISS:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0007015; P:actin filament organization; IBA:GO_Central.
DR   GO; GO:0045176; P:apical protein localization; IDA:HGNC-UCL.
DR   GO; GO:0007420; P:brain development; IEP:HGNC-UCL.
DR   GO; GO:0043010; P:camera-type eye development; IEP:HGNC-UCL.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; IMP:HGNC-UCL.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0043482; P:cellular pigment accumulation; IMP:HGNC-UCL.
DR   GO; GO:0043583; P:ear development; IEP:HGNC-UCL.
DR   GO; GO:0032401; P:establishment of melanosome localization; IMP:HGNC-UCL.
DR   GO; GO:0008057; P:eye pigment granule organization; IMP:HGNC-UCL.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; IMP:HGNC-UCL.
DR   GO; GO:0032438; P:melanosome organization; IMP:HGNC-UCL.
DR   Gene3D; 2.30.42.10; -; 1.
DR   InterPro; IPR014800; ASD1_dom.
DR   InterPro; IPR014799; ASD2_dom.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR027686; Shroom2.
DR   InterPro; IPR027685; Shroom_fam.
DR   PANTHER; PTHR15012; PTHR15012; 1.
DR   PANTHER; PTHR15012:SF8; PTHR15012:SF8; 1.
DR   Pfam; PF08688; ASD1; 1.
DR   Pfam; PF08687; ASD2; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS51306; ASD1; 1.
DR   PROSITE; PS51307; ASD2; 1.
DR   PROSITE; PS50106; PDZ; 1.
PE   2: Evidence at transcript level;
KW   Actin-binding; Cell junction; Cell membrane; Cytoplasm; Cytoskeleton;
KW   Developmental protein; Membrane; Microtubule; Reference proteome;
KW   Tight junction.
FT   CHAIN           1..1726
FT                   /note="Protein Shroom2"
FT                   /id="PRO_0000286065"
FT   DOMAIN          79..159
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          788..877
FT                   /note="ASD1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00637"
FT   DOMAIN          1427..1721
FT                   /note="ASD2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00638"
FT   REGION          294..373
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          425..451
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          657..676
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          697..785
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          913..968
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1007..1080
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1092..1120
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1166..1240
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1269..1299
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1471..1499
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        294..330
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        731..759
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        765..785
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        917..935
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1020..1043
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1057..1080
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1102..1118
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1185..1237
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1269..1291
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1471..1495
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1726 AA;  195259 MW;  932DE44A9AE58A23 CRC64;
     MLVLGCLQCF TSAWGFASRR ICHSSSATPG QHSVGLGHGY QHGAQSWAER FLLRYKGLLW
     FVGSRAHSGG EETNGKLQAG GCYSYWRGSL GIYFERGKEH GEPLIITKVE DGNKAADILM
     AGDEIVNIND QQLLGYRQEA ICLVKGSHKI LKMIVKRRND ISYRPHSWHS NKLIESAMDT
     VTPQMSNASP FWNARYRSSS SSHDLSNPWD QTSLQRNSGH FSSMGSMDSI DQTYQFGRLS
     SAKSNNSIDY VGSQNKRDSA YGSFSASFST PDHTLSKTAS ASTENILYKN NEWDNTKLGY
     GKTSPSMNEV RRSADRQVLQ STSINETSKI QRTEDNTEPR YSGRSNFGPV WNIPDKKKTA
     SPPPPPPPQR SDSYAVTKIH EKPTNLMHLD ASSTQHFNVA NRSQAKPDWS LEISEQQRPI
     RAHDRTVADT RRTSNSSYHA GLNADQGLSP YKDKYPSNLP NVSRIQASLS TNDVRFAQPA
     YNYHHQRQYS DESTLFQSTR TSAQHKSQQQ PMKYESSVNQ VPSDLTYVYH PHQFRAPATS
     AGFSSGKQNV ENNGQNHFHV VSIKHPQGNT THHQFKEEEN YAPEVNSGRK SVQPENTVIS
     IEIPAYSLPQ ESFEPSQINC EKNYLKISEK KDNYLGNNEQ IINKTTGYSE EKCNDRFSQL
     DHSEKGSYRS SQDYSWRKEE NKITPLVTPM LHSLAQEGRN RSESFPDTGN EKLSFPDAGK
     QSRRSDRFAT TLRNEIQQRR ARLQKSKSTA ALTESNETET SDNWKQDSLE SMSPTSEGSF
     SSTYRSHLQE AQARVLRATS FKRRDLDTGI SDHLSLFQDR NMQISSFSGL SLDPVQPKKN
     TAVNSSQNVS RIGARKRFTT QQKLMSYSEP EKINEVGVED QYNFRTENST KRTVGSFADR
     WKFFEETSKC AQPKVPPKVV SSSQSEETSE IAINRDYAKS SEGQESKRAL AVSGQNPADE
     NGFPDKVTTE RRQRLGTFAE YEASWKEQKT QLERKNSGRC HSADNILDAD LEQNPKAQYI
     HERSKSSPTT DFYAQAAAVE SKQQSESVRR DTENSNSTHC RSSTGDSPTR TVEAGDQCGA
     TNEQEVLTCN TKWKPHDKSF PIPETSNESQ QSRARSGTLP NDYRFAHENV NQGNRDISFS
     AVPISEACPD FSNADSDQLQ DHPSVFKKRS AAPQRPPPPK LENKYWRQNG SSSSLATSSE
     SLLTAQARRA QSYSPSSQDT FPPQSLQKQS PSTYPDKNPS IHIYDYQLSV PPENDRYHLE
     KKYFESELSS KSHLQIPGME PSRSPSPQFA PQKLTDKPPL LVPEENLSRI ERVIDNTTVK
     MVPIKIVHSE THAEKESRHN LLSAIEPTAL PTGLAKDQLK TLSTSEQSYS RFCAYTRQES
     REEEESRVTD LYSCQRNAED DNENDVSSLA PSNAKSKDAI YADLKSEELV REIVDKDKSL
     ADILDPNAKM RTTMDLMEGI FPKDEHLLEE AQQRRKHLPK IPSPRSTDDK KDEQNVPSAV
     SLTTSSTYYS TSAAKAELLI KMKDMQEQQH IAENSEDELG QNLSEKKQEL IDSISKKLQV
     LRDAKETLLE DVQCNNALGE EVEIIVKEVC KPNEFDKFRM FIGDLEKIVN LLLSLSGRLA
     RVENALNNLD ETVSPEERKT LLEKRKLLTR QHEDAKELKE NLDRRERTVY EILANYLNEE
     NLADYEHFVK MKSALILEQR ELEDKIKLRE SQLKCLTDSL PLDRIK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025